Drug intelligence / Profile preview

cynarine

Development stage
Preclinical
Lead developer
Laboratoires Beytout
Modality
Small Molecules
Administration
Oral
01

Overview

Cynarine is a naturally occurring **small molecule phenolic compound** isolated from artichoke and best known chemically as **1,3-dicaffeoylquinic acid**. It is not a modern proprietary pipeline asset from a single biotech developer, but rather a plant-derived bioactive that has appeared in historical pharmaceutical products and remains available as a research chemical and as a constituent of artichoke-based nutraceutical preparations. Reported activities include **cholagogue and choleretic effects** that promote bile secretion, along with antioxidant, hepatoprotective, antihistaminic, antiviral, and antilipemic properties. Mechanistic literature cited in the provided context indicates effects on **CD28 of T-cell receptors**, induction of **Nrf2 nuclear translocation**, restoration of glutathione and reactive oxygen species balance, and inhibition of mitochondrial depolarization. It has been investigated or used in contexts such as digestive disorders, hypercholesterolemia, and non-alcoholic fatty liver disease, although evidence is heterogeneous and cynarine is better characterized as a natural product and nutraceutical ingredient than as a currently developed prescription pharmaceutical.

Brand names
Cynarine 75Cynarine75Cynarine-75
Other names
cynarin1,3-dicaffeoylquinic acid
02

Targets

CACNA1A (P-type Calcium Channel)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)GSK3 (Glycogen synthase kinase 3 beta)

Beyond the preview

Go deeper on cynarine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cynarine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call